Prevalence and association of metabolic syndrome components with benign prostate hyperplasia

Hundesa Emana Urgesa; Tesfaye Adugna Leta; Teka Obsa Feyisa; Amanuel Hika Bati; Kassa Tefera Tulu; Bedasa Addisu Nasi; Zerihun Aseffa Tereffe

doi:10.1186/s40842-025-00266-0

February 1, 2026Cardiovascular Diabetology – Endocrinology ReportsOpen Access

Prevalence and association of metabolic syndrome components with benign prostate hyperplasia

View Full Paper

Ask AI

Bookmark

Share

Key Points

This study aims to explore the relationship between metabolic syndrome components and benign prostate hyperplasia.
Identified components of metabolic syndrome
Analyzed their association with prostate gland enlargement
Emphasized the significance of early diagnosis
Metabolic syndrome components correlated with increased prostate size
Highlights the need for proactive treatment options

Implication

Observational study finds metabolic syndrome components predict prostate enlargement, suggesting early intervention is vital.

Abstract

According to our study, components of metabolic syndrome are the predictor variables for the enlargement of the prostate gland highlighting the importance of early diagnosis and treatment to alleviate further complications.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Urgesa et al. (2026) studied this question.

synapsesocial.com/papers/698433a5f1d9ada3c1fb0ec3 https://doi.org/10.1186/s40842-025-00266-0

View Full Paper

Ask AI

Bookmark

Share

Prevalence and association of metabolic syndrome components with benign prostate hyperplasia

Key Points

Implication

Abstract

Discussion

Cite This Study

Prevalence and association of metabolic syndrome components with benign prostate hyperplasia

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading